| CASE REPORT |
|
| Year : 2021 | Volume
: 3
| Issue : 1 | Page : 6 |
|
|
Choroidal osteoma with choroidal neovascularization treated with bevacizumab in a young male patient
Jorge Henrique Cavalcante Tavares, Guilherme Sturzeneker, Melina Correia Morales, Rubens N Belfort
Department of Ophthalmology and Visual Sciences, Paulista School of Medicine, Federal University of São Paulo, São Paulo, Brazil
Correspondence Address:
Dr. Jorge Henrique Cavalcante Tavares
Department of Ophthalmology and Visual Sciences, Paulista School of Medicine, Federal University of São Paulo, São Paulo
Brazil
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/pajo.pajo_58_20
|
|
|
The purpose of the study is to report a case of choroidal neovascularization (CNV) related to choroidal osteoma treated with intravitreal injections of bevacizumab. This was a case report in which antivascular endothelial growth factor intravitreal injections were used to treat choroidal osteoma-related CNV. A 27-year-old man with a history of blurred vision in his left eye for 15 days presented best-corrected visual acuity (BCVA) of 20/60. Fundus examination, ultrasonography, fluorescein angiography, and optical coherence tomography revealed a nasal and superior juxtapapillary choroidal osteoma with a choroidal neovascular membrane, associated with serous retinal detachment affecting the macula. After three intravitreal injections of bevacizumab, the patient improved to a BCVA of 20/30 and partial resolution of subretinal fluid. Choroidal osteoma with CNV may present a good response to bevacizumab therapy.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
